Peter Loftus

They've been this sort of middleman in the industry that negotiates prices for these drugs.

CVS Caremark is one, Express Scripts is one, OptumRx.

The drug companies say that that can really distort the pricing.

And so by going directly to the patient, that's a way to get around the middlemen and just offer a discounted price that is what it is.

The industry trade group for these pharmacy benefit managers, they say that they believe they offer valuable services that also result in lower net pricing for everybody involved.

And if patients are dealing with their pharmacy, that's an extra level of protection, making sure that they're taking the right drug and not having drug interactions, that sort of thing.

Thanks for having me.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Right. All right, have you heard of this so-called miracle drug Ozempic?

Right. All right, have you heard of this so-called miracle drug Ozempic?

Right. All right, have you heard of this so-called miracle drug Ozempic?

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.